Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.225
-0.040 (-3.16%)
Jul 23, 2026, 2:14 PM EDT - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $29.31 million as of July 23, 2026. Its market cap has decreased by -76.14% in one year.
Market Cap
29.31M
Enterprise Value
20.82M
1-Year Change
-76.14%
Ranking
Category
Stock Price
$1.23
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $29.31M, a decrease of -80.73%. That is a compound annual growth rate of -57.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 29.31M | -79.40% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 37.27M |
| Veru Inc. | 37.00M |
| Nutriband | 36.79M |
| Lite Strategy | 35.22M |
| Estrella Immunopharma | 34.43M |
| Aligos Therapeutics | 33.54M |
| Serina Therapeutics | 31.86M |
| BriaCell Therapeutics | 31.50M |